FORT LEE, N.J., March 28 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global specialty pharmaceutical company, announced today that Alpharma's senior management will provide an overview of the company's business at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference on Wednesday, April 5, 2006 at 9:00 AM Eastern Daylight Time at the Millennium Broadway Hotel in New York City.
This presentation will be webcast live and can be accessed through Alpharma's website, http://www.alpharma.com/.
An archived version will be available for 90 days after the live presentation and can be accessed at the same location.
Alpharma press releases are also available at our website: http://www.alpharma.com/.
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
